A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity employing NK or high-affinity NK cells in combination with cetuximab.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Jeffrey Schlom |
| Publication date | July 28, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |